EP3716952
Skammtaform sem innihalda blóðvökva-kallikrein-hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.11.2018EP published:
5.1.2022EP application number:
18815293.8
EP translation filed:
8.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
27.11.2038Expiry date:
27.11.2026Next due date:
30.11.2026
Title in English:
DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITORLanguage of the patent:
English
Timeline
Today
28.11.2018EP application
5.1.2022EP Publication
8.3.2022Translation submitted
15.4.2022Registration published
27.11.2026Expires
Owner
Name:
Kalvista Pharmaceuticals LimitedAddress:
Porton Science Park Bybrook Road, Porton Down, Salisbury SP4 0BF Wiltshire, GB
Inventor
Name:
COLLETT, John HermanAddress:
Deeside Flintshire CH5 2NS, GB
Name:
COOK, Gary PaulAddress:
Westford Massachusetts 01886, US
Name:
FARRAR, Jamie JosephAddress:
Deeside Flintshire CH5 2NS, GB
Name:
FRODSHAM, Michael JohnAddress:
Deeside Flintshire CH5 2NS, GB
Name:
ROE, Michael BryanAddress:
Porton Down Wiltshire SP4 0BF, GB
Name:
TODD, Richard SimonAddress:
Porton Down Wiltshire SP4 0BF, GB
Name:
WARD, Robert NeilAddress:
Deeside Flinshire CH5 2NS, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762592242 PDate:
29.11.2017Country:
US
Number:
201721515Date:
21.12.2017Country:
GB
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/48, A61K 9/16, A61K 31/00, A61K 31/444
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 6.10.2022
Expires: 27.11.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 9.11.2023
Expires: 27.11.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 9.11.2023
Expires: 27.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.10.2024
Expires: 27.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.11.2025
Expires: 27.11.2026
Payer: Árnason Faktor ehf.